Mary Fidler to Disease-Free Survival
This is a "connection" page, showing publications Mary Fidler has written about Disease-Free Survival.
Connection Strength
0.062
-
Clinical features and outcomes in young adults with oral tongue cancer. Am J Otolaryngol. 2019 Jan - Feb; 40(1):93-96.
Score: 0.035
-
Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer. J Clin Oncol. 2015 Jan 10; 33(2):189-94.
Score: 0.027